The term GLP-1 agonist refers to a type of medication that medical professionals may prescribe to patients needing treatment for high blood glucose levels or who may need assistance with managing their weight
Robust healthcare systems, the early uptake of innovative GLP-1 therapies including Ozempic and Wegovy, and favorable reimbursement are additional elements that help maintain market leadership
Regular exercise improves insulin sensitivity, supports lean muscle retention, and helps prevent weight regaineven if the medication controls appetite
Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, led an engaging exploration of the benefits and potential pitfalls with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting in their presentation, GLP-1s in Oncology: Miracle, Misdirection, or Missed Opportunity
Some of these clinics may offer prescription BPC-157 both as a monotherapy and as part of a stack with complementary peptides that may synergistically enhance the anti-inflammatory and wound-healing effects for example, GHK-Cu, KPV, and TB-500 (a fragment of TB4)
In addition, Alterme Injection (3ml Cartridge + 10 Needles) is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring